SCHEMBL3338562

SCHEMBL3338562

CN1CCOc2cc(S(=O)(=O)n3nc(N4CCN(C(=O)O)C(C(C)(C)C)C4)c4ccccc43)ccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.45
PTGES2 Q9H7Z7 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 1/20 0.39
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
MAPT P10636 1/20 0.37
HDAC4 P56524 3/20 0.37
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC10 Q969S8 2/20 0.37
HDAC11 Q96DB2 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
HDAC9 Q9UKV0 2/20 0.37
HDAC5 Q9UQL6 2/20 0.37
ALDH1A1 P00352 2/20 0.37
RECQL P46063 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3337670 0.83 GBA1 (0.54) GBA1PTGES2L3MBTL1POLBHCRTR1
SCHEMBL3338565 0.82 GBA1 (0.45) GBA1PTGES2L3MBTL1POLBHCRTR1
SCHEMBL3339496 0.80 GBA1 (0.49) GBA1PTGES2L3MBTL1POLBHCRTR1
SCHEMBL3343929 0.69 GBA1 (0.42) GBA1PTGES2HCRTR1HCRTR2ALDH1A1
SCHEMBL4740976 0.67 GBA1 (0.49) GBA1L3MBTL1ALDH1A1LMNAPKM
SCHEMBL2953627 0.67 L3MBTL1 (0.71) GBA1PTGES2L3MBTL1POLBMAPT
SCHEMBL3337520 0.65 TSHR (0.55) POLBALDH1A1LMNARAB9A
SCHEMBL1774568 0.65 HTR6 (0.58)
SCHEMBL1544929 0.65 HTR6 (0.56) POLB
SCHEMBL14140333 0.65 USP9X (0.42) GBA1PTGES2L3MBTL1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152177-A1 COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-06-17 US disclosed
US-7696229-B2 Compounds having 5-HT6 receptor affinity MEMORY PHARMACEUTICALS CORPORATION (US) 2010-04-13 US disclosed
US-20080039462-A1 Compounds having 5-HT6 receptor affinity MEMORY PHARMACEUTICALS CORPORATION 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152177-A1 COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR3B, HTR1B GBA1 2990/4885PTGES2 2187/4885L3MBTL1 2286/4885
US-20080039462-A1 Compounds having 5-HT6 receptor affinity HTR6, HTR3B, HTR1B GBA1 2990/4885PTGES2 2187/4885L3MBTL1 2286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.